Clinical Impact of the Location of Lymph Node Metastases After Neoadjuvant Chemotherapy for Middle and Lower Thoracic Esophageal Cancer

Hiroshi Miyata,Keijirou Sugimura,Makoto Yamasaki,Tomoki Makino,Koji Tanaka,Eiichi Morii,Takeshi Omori,Kazuyoshi Yamamoto,Yoshitomo Yanagimoto,Masahiko Yano,Shin-ichi Nakatsuka,Masaki Mori,Yuichiro Doki

Clinical Impact of the Location of Lymph Node Metastases After Neoadjuvant Chemotherapy for Middle and Lower Thoracic Esophageal Cancer

2019

Hiroshi Miyata
Keijirou Sugimura
Makoto Yamasaki
Tomoki Makino
Koji Tanaka
Eiichi Morii
Takeshi Omori
Kazuyoshi Yamamoto
Yoshitomo Yanagimoto
Masahiko Yano
Shin-ichi Nakatsuka
Masaki Mori
Yuichiro Doki

Background In the current cancer staging systems, the location of lymph node (LN) metastases is not considered, although LN status is defined according to the number of LN metastases.

Keywords:

Esophagectomy
Cancer staging
Lymph node
Esophageal cancer
General surgery
Neoadjuvant therapy
Metastasis
Chemotherapy
Medicine
Radiology
thoracic esophageal cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations